CTOs on the Move

Tia

www.asktia.com

 
Founded in 2017 by Carolyn Witte and Felicity Yost, Tia is bringing the new standard of care for women for women in NY, LA, SF and PHX. Blending in-person and virtual care services, Tia`s “Whole Woman, Whole Life” care model fuses gynecology, primary care, mental health and evidence-based wellness services to treat women comprehensively. By bringing collaborative, comprehensive, and compassionate care, Tia is raising the bar for women and empowering them to achieve optimal health, on their terms.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.asktia.com
  • 548 Market Street Suite 45295
    San Francisco, CA USA 94104
  • Phone: 855.586.1306

Executives

Name Title Contact Details

Funding

Tia raised $24.2M on 05/28/2020

Similar Companies

Vitamin World

Vitamin World is a Holbrook, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ChromaDex

ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex`s patent portfolio. ChromaDex delivers Niagen® as the sole active ingredient in its consumer product, Tru Niagen® — available at www.truniagen.com and through partnerships with global retailers and distributors.

Superior Healthcare Management

Superior Healthcare Management is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pam Gene

Pam Gene is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SetPoint Medical

SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.